Results 11 to 20 of about 9,013,987 (358)

Factors associated with pneumococcal nasopharyngeal carriage: A systematic review

open access: yesPLOS Global Public Health, 2022
Pneumococcal disease is a major contributor to global childhood morbidity and mortality and is more common in low- and middle-income countries (LMICs) than in high-income countries.
Eleanor Frances Georgina Neal   +3 more
doaj   +2 more sources

Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England

open access: yesEmerging Infectious Diseases, 2022
During July–December 2021, after COVID-19 restrictions were removed in England, invasive pneumococcal disease incidence in children
M. Bertran   +8 more
semanticscholar   +1 more source

Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study

open access: yesClinical Infectious Diseases, 2021
Background The incidence of invasive pneumococcal disease (IPD) declined during the COVID-19 pandemic. Previous studies hypothesized that this was due to reduced pneumococcal transmission resulting from non-pharmaceutical interventions.
D. Danino   +7 more
semanticscholar   +1 more source

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults

open access: yesMicroorganisms, 2021
Pneumococcal disease is one of the most common and severe vaccine-preventable diseases (VPDs). Despite the advances in antimicrobial treatment, pneumococcal disease still remains a global burden and exhibits a high mortality rate among people of all ages
Nobuhiro Asai, Hiroshige Mikamo
doaj   +1 more source

Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis

open access: yesScientific Reports, 2021
Risk factors associated with mortality in invasive pneumococcal disease remain unclear. The present work is a meta-analysis of studies that enrolled only patients with invasive pneumococcal disease and reported on mortality.
Hao Chen   +5 more
semanticscholar   +1 more source

Clinical and economic burden of pneumococcal disease among adults in Sweden: A population-based register study.

open access: yesPLoS ONE, 2023
Pneumococcal disease is a major cause of clinical and economic burden worldwide. This study investigated the burden of pneumococcal disease in Swedish adults.
Natalie Zarabi   +6 more
doaj   +1 more source

Transmission factors and exposure to infections at work and invasive pneumococcal disease

open access: yesAmerican Journal of Industrial Medicine, Volume 66, Issue 1, Page 65-74, January 2023., 2023
Abstract Background Working in close contacts with coworkers or the general public may be associated with transmission of invasive pneumococcal disease (IPD). We investigated whether crowded workplaces, sharing surfaces, and exposure to infections were factors associated with IPD.
Kjell Torén   +4 more
wiley   +1 more source

Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age

open access: yesInfectious Disease and Therapy, 2021
The widespread implementation of pneumococcal conjugate vaccines (PCVs) has significantly reduced the burden of pneumococcal disease around the world. Although licensed 10-valent (PCV10) and 13-valent (PCV13) vaccines have considerably reduced mortality ...
M. Wasserman   +7 more
semanticscholar   +1 more source

Invasive pneumococcal disease [PDF]

open access: yesArchives of Disease in Childhood - Education and Practice, 2011
Streptococcus pneumoniae , the pneumococcus, is a Gram-positive diplococcus with more than 90 serotypes determined by the polysaccharide composition of its capsule. It is carried asymptomatically in approximately 50% of people.1 It can cause both non-invasive and invasive disease.
Elise Randle, David Inwald, Nelly Ninis
openaire   +3 more sources

COVID‐19 and myasthenia gravis: A review of neurological implications of the SARS‐COV‐2

open access: yesBrain and Behavior, Volume 12, Issue 12, December 2022., 2022
Abstract Introduction This review highlights the potential mechanisms of neuromuscular manifestation of COVID‐19, especially myasthenia gravis (MG). Methods An extensive literature search was conducted by two independent investigators using PubMed/MEDLINE and Google Scholar from its inception to December 2020. Results Exacerbations of clinical symptoms
Syed Muhammad Ismail Shah   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy